Research funded by the British Heart Foundation has found that epigallocatechin-3-gallate (EGCG), an extract from green tea, could be effective against the types of plaques which can cause heart attacks and strokes.
Over the past decade there has been an explosion of research into the beneficial health properties of the green tea extract epigallocatechin-3-gallate (EGCG). Studies carried out at the Dr. Rath Research Institute under the leadership of Dr. Aleksandra Niedzwiecki have played a fundamental role in helping inspire this research, and have shown how EGCG can address multiple factors in the control of not just heart disease but also cancer.
EGCG has particularly impressive abilities in the control of cancer. Working in synergy with other micronutrients including vitamin C, lysine and proline, it can help control the growth and spread of the disease. Studies conducted at the Dr. Rath Research Institute have shown how, when used together, these micronutrients can prevent cancer metastasis by simultaneously inhibiting the action of collagen digesting enzymes and the growth of new blood vessels to tumors. You can learn more about Dr. Rath’s approach to eradicating cancer with EGCG and other micronutrients by reading this article on our website.